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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 63, Revision 1 
(FGE.63Rev1): 
Consideration of aliphatic secondary alcohols, ketones and related esters evaluated by 
JECFA (59th and 69th meetings) structurally related to saturated and unsaturated 
aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated 
linear or branched-chain carboxylic acids evaluated by EFSA in FGE.07Rev4 (2012)1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to consider evaluations of flavouring substances assessed since 
2000 by the Joint FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide 
whether further evaluation is necessary, as laid down in Commission Regulation (EC) No 1565/2000. 
The present consideration concerns a group of 19 aliphatic secondary alcohols, ketones and related 
esters evaluated by the JECFA at the 59th and 69th meetings in 2002 and 2008. This revision is made 
due to inclusion of six additional substances, 4,8-dimethyl-3,7-nonadien-2-ol, 6-methylhepta-3,5-dien-
2-one, octa-1,5-dien-3-one, (E,E)-3,5-octadien-2-one, (3Z)-4,8-dimethyl-3,7-nonadiene-2-one and 4,8-
dimethyl-3,7-nonadien-2-yl acetate [FL-no: 02.252, 07.099, 07.190, 07.247, 07.256 and 09.936] 
cleared for genotoxicity concern. The substances were evaluated through a stepwise approach that 
integrates information on structure-activity relationships, intake from current uses, toxicological 
threshold of concern, and available data on metabolism and toxicity. The Panel agrees with the 
application of the Procedure as performed by the JECFA for all 19 substances considered in this FGE 
and agrees with the JECFA conclusion, “No safety concern at estimated levels of intake as flavouring 
substances” based on the MSDI approach.  
© European Food Safety Authority, 2012 
                                                     
1 On request from the Commission, Question No EFSA-Q-2012-00518, EFSA-Q-2012-00517, EFSA-Q-2012-00516, 
   EFSA-Q-2012-00515, EFSA-Q-2012-00514, EFSA-Q-2012-00513, adopted on 27 September 2012. 
2  Panel members: Ulla Beckman Sundh, Mona-Lise Binderup, Leon Brimer, Laurence Castle, Karl-Heinz Engel, Roland 
Franz, Nathalie Gontard, Rainer Gürtler, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean Claude Lhuguenot, 
Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Maria de Fatima Tavares Poças, Fidel Toldra, Detlef 
Wölfle. Correspondence: cef@efsa.europa.eu. 
3 Acknowledgement: The Panel wishes to thank the members of the Working Group on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Leon Brimer, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, Henrik 
Frandsen, Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard Mulder, 
Karin Nørby, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the preparatory work on 
this scientific Opinion. 
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SUMMARY 
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000. These flavouring substances are listed in the Register, which was adopted by 
Commission Decision 1999/217/EC and its consecutive amendments. 
In FGE.63 the EFSA evaluated 13 flavouring substances (EFSA, 2008ae) from a group of 39 
flavouring substances consisting of aliphatic secondary alcohols, ketones and related esters evaluated 
by the JECFA at its 59th meeting (JECFA, 2003a). At its 69th meeting (JECFA, 2009c), the JECFA 
evaluated an additional 17 aliphatic secondary alcohols, ketones and related esters. The present 
revision of FGE.63, FGE.63Rev1, includes the consideration of six additional substances, 4,8-
dimethyl-3,7-nonadien-2-ol, 6-methylhepta-3,5-dien-2-one, octa-1,5-dien-3-one, (E,E)-3,5-octadien-2-
one, (3Z)-4,8-dimethyl-3,7-nonadiene-2-one and 4,8-dimethyl-3,7-nonadien-2-yl acetate [FL-no: 
02.252, 07.099, 07.190, 07.247, 07.256 and 09.936]. Three of these substances [FL-no: 07.099, 07.247 
and 07.256] were evaluated by the JECFA at the 59th meeting (JECFA, 2003a) and three substances 
[FL-no: 02.252, 07.190 and 09.936] were evaluated by the JECFA at its 69th meeting (JECFA, 2009c). 
These six substances are α,β-unsaturated ketones or may be metabolised to α,β-unsaturated ketones 
and were originally allocated to and evaluated in FGE.206 (EFSA, 2011c) in which they were 
considered not to be of concern with respect to genotoxicity. Therefore, the present revision of 
FGE.63, FGE.63Rev1, considers 19 flavouring substances evaluated by the JECFA.  
The Panel concluded that the six additional substances fit well together with the 13 aliphatic secondary 
alcohols, ketones and related esters considered in the FGE.63. 
The Panel concluded that the 19 substances in the JECFA flavouring group of aliphatic secondary 
alcohols, ketones and related esters are structurally related to the group of 49 saturated and unsaturated 
aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or 
branched-chain carboxylic acids evaluated in the Flavouring Group Evaluation 07, Revision 4 
(FGE.07Rev4). 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 19 
substances considered in this FGE.  
For all 19 substances the JECFA evaluation is based on MSDI values derived from production figures 
from the EU. 
For three candidate substances [FL-no: 02.252, 07.190 and 09.936], the Industry has submitted normal 
and maximum use levels. For [FL-no: 02.252 and 09.936], which are expected to be metabolised to 
innocuous products, the mTAMDI values are below their respective thresholds of concern for 
structural class I (1800 microgram/person/day) and class II (540 microgram/person/day). For 
substance [FL-no: 07.190] the mTAMDI value is above the threshold of concern for structural class II 
of 540 microgram/person/day to which it is allocated. Therefore, for this substance more reliable 
exposure data are required. On the basis of such additional data, the flavouring substance should be 
reconsidered along the steps of the Procedure. Following this procedure additional toxicological data 
might become necessary. For the remaining 16 substances evaluated through the Procedure use levels 
are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more 
refined exposure assessment in order to finalise the evaluation. 
In order to determine whether the conclusion for the 19 JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
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specifications including complete purity criteria and identity are available for all 19 JECFA-evaluated 
substances.  
Thus, for all 19 JECFA evaluated aliphatic secondary alcohols, ketones and related esters [FL-no: 
02.252, 07.015, 07.069, 07.099, 07.100, 07.114, 07.123, 07.151, 07.190, 07.240, 07.247, 07.249, 
07.256, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] the Panel agrees with the JECFA 
conclusion “no safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach.    
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances, the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a).  
Commission Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
In the period 2000 - 2008, during its 55th, 57th, 59th, 61st, 63rd, 65th, 68th and 69th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE AS PROVIDED BY THE COMMISSION 
The European Food Safety Authority (EFSA) is requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation (EC) 
No 1565/2000 (EC, 2000a). These flavouring substances are listed in the Register, which was adopted 
by Commission Decision 1999/217/EC (EC, 1999a) and its consecutive amendments. The evaluation 
programme was finalised at the end of 2009. 
The Commission requested EFSA, based on additional submitted data on genotoxicity, to carry out re-
evaluation of the six flavouring substances [FL-no: 02.252, 07.099, 07.190, 07.247, 07.256 and 
09.936] and depending on the outcome to proceed to the evaluation of these flavouring substances 
through the Procedure, also according to Commission Regulation (EC) No 1565/2000 (EC, 2000a). 
ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), hereafter named the “EFSA Procedure”. 
This Procedure is based on the Opinion of the Scientific Committee on Food (SCF, 1999a), which has 
been derived from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on 
Food Additives (JECFA, 1995; JECFA, 1996a; JECFA, 1997a; JECFA, 1999b), hereafter named the 
“JECFA Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (the Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
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In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006c). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified “Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original Procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”)” (JECFA, 1999b).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999a), the Panel has in its evaluation focussed on a 
possible genotoxic potential of the flavouring substances or of structurally related substances. 
Generally, substances for which the Panel has concluded that there is an indication of genotoxic 
potential in vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are 
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provided. Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated 
through the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of the 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
At its 59st meeting the JECFA evaluated a group of 39 flavouring substances consisting of aliphatic 
secondary alcohols, ketones and related esters (JECFA, 2003a). One of the JECFA evaluated 
substances is not in the Register [(E,R)-3,7-dimethyl-1,5,7-octatrien-3-ol (JECFA No: 1154)], and 25 
substances [FL-no: 02.023, 02.099, 02.102, 02.104, 02.136, 02.193, 07.044, 07.048, 07.081, 07.082, 
07.099, 07.101, 07.102, 07.104, 07.105, 07.106, 07.107, 07.121, 07.138, 07.139, 07.177, 07.188, 
07.244, 07.247 and 07.256] are α,β-unsaturated ketones or precursors for such, which have been 
considered together with other α,β-unsaturated substances. FGE.63 therefore only dealt with 13 
JECFA evaluated substances (EFSA, 2008ae). 
FGE Opinion adopted by 
EFSA 
Link No. of candidate 
substances 
63 7 July 2007 http://www.efsa.europa.eu/en/efsajournal/pub/706.htm 13 
63Rev1 26 Sep. 2012  19 
 
The present revision of FGE.63, FGE.63Rev1, includes the consideration of six additional substances 
[FL-no: 02.252, 07.099, 07.190, 07.247, 07.256 and 09.936]. These six substances are α,β-unsaturated 
ketones or may be metabolised to α,β-unsaturated ketones and were originally allocated to and 
evaluated in FGE.206 (EFSA, 2011c) in which they were considered not to be of concern with respect 
to genotoxicity. Three of these substances [FL-no: 07.099, 07.247 and 07.256] were evaluated by the 
JECFA at the 59th meeting (JECFA, 2003a) and three substances [FL-no: 02.252, 07.190 and 09.936] 
were evaluated at the 69th meeting (JECFA, 2009c).  
Since the evaluation of FGE.63 in 2007, EU production volumes have been provided for three 
substances [FL-no: 07.069, 07.100 and 09.658] (EFFA, 2010a), for which the evaluation could not be 
finalised, due to lack of these data. Based on the newly submitted EU production volumes the 
substances have already been evaluated in FGE.964 (EFSA, 2011al), but for the sake of completion, 
the information has also been included here as well. 
Finally, information on the stereoisomeric composition has been provided (EFFA, 2010a) for six 
substances [FL-no: 07.069, 07.114, 09.657, 09.658, 09.923 and 09.925] since the previous evaluation 
of FGE.63 (EFSA, 2008ae). 
                                                     
4 Consideration of 88 flavouring substances considered by EFSA for which EU production volumes / anticipated production volumes have been submitted on 
request by DG SANCO. 
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1. Presentation of the Substances in the JECFA Flavouring Group 
1.1. Description 
1.1.1. JECFA Status 
This FGE deals with 19 JECFA evaluated substances. Sixteen substances from the 59th meeting, 2002 
and three substances from the 69th meeting, 2008: 
• Of the 39 aliphatic secondary alcohols, ketones and related esters evaluated by the JECFA at 
the 59th meeting (JECFA, 2003a) one is not in the Register [(E,R)-3,7-dimethyl-1,5,7-
octatrien-3-ol (JECFA No: 1154)], and 25 substances [FL-no: 02.023, 02.099, 02.102, 02.104, 
02.136, 02.193, 07.044, 07.048, 07.081, 07.082, 07.099, 07.101, 07.102, 07.104, 07.105, 
07.106, 07.107, 07.121, 07.138, 07.139, 07.177, 07.188, 07.244, 07.247 and 07.256] are α,β-
unsaturated ketones or precursors for such, which have been considered together with other 
α,β-unsaturated substances. Of these 25 substances, three substances [FL-no: 07.099, 07.247 
and 07.256] were evaluated in FGE.206 (EFSA, 2011c) in which they were considered not to 
be of concern with respect to genotoxicity. These three substances are included in this revision 
of FGE.63. Therefore, from the 59th JECFA meeting 16 substances are considered in this 
FGE.63Rev1. 
• Of the 17 aliphatic secondary alcohols, ketones and related esters evaluated by the JECFA at 
the 69th meeting (JECFA, 2009c) five are not in the Register [(E,Z)-4-octen-3-one (JECFA 
No: 1843), (E)-2-nonen-4-one (JECFA No: 1844), (E)-5-nonen-2-one (JECFA No: 1845), 10-
undecen-2-one (JECFA No: 1849) and 8-nonen-2-one (JECFA No: 1851)], six have been 
evaluated in other FGEs to be of no safety concern [FL-no: 02.253, 07.097, 07.239, 09.565, 
09.822 and 09.938], and three substances [FL-no: 02.155, 09.281 and 09.282] have been 
evaluated in FGE.205 (EFSA, 2012n) in which they were considered to be of concern with 
respect to genotoxicity. The remaining three substances [FL-no: 02.252, 07.190 and 09.936] 
were evaluated in FGE.206 (EFSA, 2011c) in which they were considered not to be of 
concern with respect to genotoxicity. These three substances are included in this revision of 
FGE.63. Therefore, from the 69th JECFA meeting, three substances are considered in this 
FGE.63Rev1. 
1.1.2. EFSA Considerations 
Six of the α,β-unsaturated ketones [FL-no: 02.252, 07.099, 07.190, 07.247, 07.256 and 09.936] 
evaluated by the JECFA (JECFA, 2003a; JECFA, 2009c) were evaluated by the EFSA in FGE.206 
(EFSA, 2011c) and were considered not to be of concern with respect to genotoxicity. 
The Panel concluded that these six substances together with 13 aliphatic secondary alcohols, ketones 
and related esters considered in FGE.63 are structurally related to the group of 49 saturated and 
unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear 
or branched-chain carboxylic acids evaluated by EFSA in Flavouring Group Evaluation 07, Revision 4 
(FGE.07Rev4) (EFSA, 2012d). 
1.2. Isomers 
1.2.1. Status 
Eight substances in the group of JECFA evaluated aliphatic secondary alcohols, ketones and related 
esters have a chiral centre [FL-no: 02.252, 07.069, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] 
and eight substances can exist as geometrical isomers [FL-no: 02.252, 07.099, 07.114, 07.123, 07.190, 
07.247, 07.256 and 09.936]. 
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1.2.2. EFSA Considerations 
Adequate information on isomeric composition is available for all substances. It is foreseen that no 
quantitative information on the stereoisomeric composition of [FL-no: 07.114] can be obtained. 
Therefore, the Panel consider the available information adequate. 
For the substance [FL-no: 07.123], the CAS register number (CASrn) is considered to specify the 
stereoisomeric composition. 
1.3. Specifications 
1.3.1. JECFA Status 
The JECFA specifications are available for all 19 substances (JECFA, 2002d; JECFA, 2009b). See 
Table 1. 
1.3.2. EFSA Considerations 
No comments. 
2. Intake Estimations 
2.1. JECFA Status 
For all 19 substances evaluated by the JECFA intake data were available for the EU, see Table 2.2.2 
and Table 3.1.  
2.2. EFSA Considerations 
For all substances, the Industry has submitted production figure for EU. Since the evaluation of 
FGE.63 in 2007, EU production volumes have been provided for three substances [FL-no: 07.069, 
07.100 and 09.658] (EFFA, 2010a), for which the evaluation could not be finalised, due to lack of 
these data. These data have been used in this consideration (see Table 2.2.2 and Table 3.1). 
For three substances [FL-no: 02.252, 07.190 and 09.936], the Industry has submitted use levels for 
normal and maximum use (Flavour Industry, 2004n) (see Table 2.2.1). Based on these normal use 
levels, mTAMDI values can be calculated (see Table 2.2.2), (EFSA, 2004d). For one substance [FL-
no: 07.190], the mTAMDI value is above the thresholds of concern for structural class II of 540 
microgram/person/day to which it is allocated. The remaining two flavouring substances [FL-no: 
02.252 and 09.936] have mTAMDI intake estimates below the threshold of concern for their structural 
class (class I and class II, respectively). 
For 16 substances use levels are needed to calculate the mTAMDIs. 
Table 2.2.1  Normal and Maximum use levels (mg/kg) available for  three JECFA evaluated substances in 
FGE.63Rev1 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
02.252 0,0005 
0,025 
0,0005 
0,025 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
0,05 
2,5 
- 
- 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
- 
- 
- 
- 
0,0005 
0,025 
- 
- 
0,05 
2,5 
0,05 
2,5 
0,0005 
0,025 
0,0005 
0,025 
07.190 3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
09.936 0,0005 
0,025 
0,0005 
0,025 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
0,05 
2,5 
- 
- 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
- 
- 
- 
- 
0,0005 
0,025 
- 
- 
0,05 
2,5 
0,05 
2,5 
0,0005 
0,025 
0,0005 
0,025 
 
 
Table 2.2.2  Estimated intakes based on the MSDI approach and the mTAMDI approach 
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FL-no EU Register name MSDI – EU 
(μg/capita/day) 
MSDI – USA 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.252 4,8-Dimethyl-3,7-nonadien-2-ol 3.0  19 Class I 1800 
09.657 1-Methylbutyl acetate 2.9 3  Class I 1800 
09.658 1-Methylbutyl butyrate 0.47 1  Class I 1800 
09.923 Hept-2-yl butyrate 3.0 3  Class I 1800 
09.924 (+/-)-3-Heptyl acetate 3.0 3  Class I 1800 
09.925 Nonan-3-yl acetate 3.0 3  Class I 1800 
07.015 6-Methylhept-5-en-2-one 100 44  Class II 540 
07.069 Tetrahydro-pseudo-ionone 0.012 0.01  Class II 540 
07.099 6-Methylhepta-3,5-dien-2-one 13 5  Class II 540 
07.100 5-Methylhex-5-en-2-one 0.24 0.3  Class II 540 
07.114 6,10,14-Trimethylpentadeca-5,9,13-
trien-2-one 
0.085   Class II 540 
07.123 Geranylacetone 41 2  Class II 540 
07.151 Decan-3-one 3.0 3  Class II 540 
07.190 Octa-1,5-dien-3-one 0.061  1600 Class II 540 
07.240 2-Methylheptan-3-one 3.0 3  Class II 540 
07.247 (E,E)-3,5-Octadien-2-one 3.0 4  Class II 540 
07.249 Undecan-6-one 3.0 3  Class II 540 
07.256 (3Z)-4,8-Dimethyl-3,7-nonadiene-2-
one 
6.1 6.6  Class II 540 
09.936 4,8-Dimethyl-3,7-nonadien-2-yl 
acetate 
3.0  19 Class II 540 
 
3. Genotoxicity Data 
3.1. Genotoxicity Studies  
3.1.1. Genotoxicity Studies - Text Taken5 from the 59th JECFA meeting (JECFA, 
2003a) 
In Vitro  
Assays for reverse mutation were performed with 6-methyl-5-hepten-2-one [FL-no: 07.015] and 6-
methyl-3,5-heptadien-2-one [FL-no: 07.099]. There was no evidence of mutagenicity for 6-methyl-5-
hepten-2-one at concentrations up to 380 µg/plate in TA98, TA100, TA1535 or TA1537 strains of 
Salmonella typhimurium (Florin et al., 1980). There was also no evidence of mutagenicity for 6-
methyl-3,5-heptadien-2-one at concentrations up to 370 µg/plate in the same strains (Florin et al., 
1980). 
In Vivo 
No in vivo studies were reported by the JECFA at the 59th meeting. 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA, see Table 2.1. 
 
3.1.2. Genotoxicity Studies - From the 69th JECFA meeting (JECFA, 2009c) 
For the substances evaluated by the JECFA at the 69th meeting no genotoxicity data were provided 
(JECFA, 2009c). 
3.2. Genotoxicity Studies - Text Taken6 from EFSA FGE.07Rev4 (EFSA, 2012d) 
In vitro / In vivo  
In vitro genotoxicity data have been reported for nine candidate substances. Negative results were 
obtained in bacterial systems (+/- metabolic activation) with six candidate substances: one saturated 
aliphatic acyclic secondary alcohol [FL-no: 02.183]; two saturated ketones [FL-no: 07.181 and 
                                                     
5 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
6 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
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07.205]; two unsaturated ketones [FL-no: 07.198 and 07.262] and the ester isopropyl hexadecanoate 
[FL-no: 09.606]. Negative results were also obtained for the candidate substances pseudo-ionone [FL-
no: 07.198], pentan-3-ol [FL-no: 02.077] and methyl-3-butan-2-one [FL-no: 07.178], the two first 
mentioned being tested for chromosomal aberrations in mammalian cells and the latter for induction of 
aneuploidy in yeast cells, respectively.  
Induction of aneuploidy in yeast cells has been demonstrated for pentan-3-one [FL-no: 07.084]. The 
effect, measured only at high concentrations, approaching cytotoxic levels, can be considered to be a 
threshold effect, not mediated by direct interaction with DNA. In addition, induction of aneuploidy 
described in the paper is strongly potentiated by ice treatments included in the experimental protocol, 
consistently with tubulin dissociation at low temperature in vitro; in the absence of this passage the 
effect is very weak. Therefore, the effect could be considered as an effect occurring only under 
unrealistic experimental conditions and the extrapolation of this result to the in vivo situation in 
humans is questionable. Furthermore, it is well recognised that the relevance of fungal systems is 
limited when induction of aneuploidy in mammalian systems has to be evaluated. 
Pseudo-ionone [FL-no: 07.198] was considered with respect to genotoxicity in FGE.206 (EFSA, 
2011c) where the Panel concluded that the data available ruled out the concern for genotoxicity. 
Pseudo-ionone was tested in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and 
TA102 in the presence or absence of S9 and it is concluded that under the test conditions applied 
pseudo-ionone is not mutagenic in bacteria. Pseudo-ionone was also evaluated in an in vitro 
micronucleus assay in human peripheral blood lymphocytes for its ability to induce chromosomal 
damage or aneuploidy in the presence and absence of rat S9 fraction as an in vitro metabolising 
system. Under the conditions of this study, pseudo-ionone was not clastogenic and/or aneugenic in 
cultured human lymphocytes. 
In vitro genotoxicity data are also available for 10 supporting substances.  
No evidence of mutagenicity obtained with either bacterial or mammalian cells systems was reported 
for: one saturated aliphatic acyclic secondary alcohol [FL-no: 02.079], five saturated [FL-no: 07.002, 
07.050, 07.017, 07.053 and 07.122] and two unsaturated [FL-no: 07.015 and 07.099] aliphatic acyclic 
ketones; two esters of an aliphatic acyclic secondary alcohol with linear aliphatic carboxylic acids 
[FL-no: 09.003 and 09.105]. 4-Methyl-2-pentanone [FL-no: 07.017] gave negative results also when 
tested for chromosomal aberration activity. 
Beside the negative results in in vitro bacterial point mutation tests, acetone [FL-no: 07.050] showed 
no evidence of increased sister chromatid exchanges in several cytogenetic assays on different 
mammalian cells, as well as no induction of chromosomal aberrations in Chinese hamster ovary cells 
up to very high concentrations. Only one test on hamster lung fibroblasts (conducted at an unspecified 
acetone concentration) and an aneuploidy induction test on Saccharomyces cerevisiae (about 7 % 
acetone) gave positive results. However, these two studies were considered not relevant on the basis of 
their poor quality and taking into account all the other negative genotoxicity results obtained with 
acetone, including results in vivo (see below).  
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was considered with respect to genotoxicity in 
FGE.206 (EFSA, 2011c) where the Panel concluded that the data available ruled out the concern for 
genotoxicity. 6-Methylhepta-3,5-dien-2-one was tested in Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 in the presence or absence of S9 and it was concluded that 
under the test conditions applied 6-methylhepta-3,5-dien-2-one is not mutagenic in bacteria. 6-
Methylhepta-3,5-dien-2-one was also evaluated in an in vitro micronucleus assay in human peripheral 
blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and 
absence of rat S9 fraction as an in vitro metabolising system. Under the conditions of this study, 6-
methylhepta-3,5-dien-2-one was not clastogenic and/aneugenic in cultured human lymphocytes. 
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In vivo data are available for four supporting substances: one saturated aliphatic secondary alcohol 
[FL-no: 02.079] and three saturated aliphatic ketones [FL-no: 07.017, 07.050 and 07.053], which 
exhibited no genotoxic potential in the micronucleus cytogenetic assay at doses approaching the LD20 
and the LD50 of the tested substances.  
Conclusion on Genotoxicity 
On the basis of available data from in vitro and in vivo tests on candidate and supporting substances, it 
can be concluded that the 49 candidate substances included in this group exhibit no genotoxic 
potential. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA see Table 2.2 and 2.3. 
3.3. Genotoxicity Studies - Text Taken7 from EFSA FGE.206 (EFSA, 2011c) 
The Industry has submitted data concerning genotoxicity studies for 6-methylhepta-3,5-dien-2-one 
[FL-no: 07.099] a representative substance for subgroup 1.2.3 in FGE.19 (EFSA, 2011c). The data 
below are of importance for the assessment, in this revision of FGE.63, of the genotoxic potential of 
six candidate substances [FL-no: 02.252, 07.099, 07.190, 07.247, 07.256 and 09.936], which have a 
structural alert for genotoxicity. 
In vitro  
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was tested in Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 in the presence or absence of S9. In the first experiment the 
concentrations tested were 1.6, 8, 40, 200, 1000 and 5000 μg/plate, and the plate incorporation 
methodology was used. Severe toxicity was observed at 5000 μg/plate in all strains (complete killing 
of bacteria). No increase in revertant colonies was observed at any of the tested concentrations. In the 
second experiment the concentrations were 20.5, 51.2, 128, 320, 800, 2000 and 5000 μg/plate of 6-
methylhepta-3,5-dien-2-one, and treatments in the presence of S9 were carried out according to the 
pre-incubation method. In the absence of S9 the standard plate incorporation method was performed. 
Slight thinning of the bacterial lawn or complete killing of the bacteria was observed in all strains at 
2000 and 5000 μg/plate in the absence of S9. In the presence of S9 cytotoxicity was observed at 800 
μg/plate and above and severe toxicity (complete killing of bacteria) was observed at 5000 μg/plate in 
all strains (Williams, 2009a). The study design complied with current recommendations (OECD 471; 
GLP) and an acceptable top concentration was achieved. There was no evidence of mutagenic effect 
induced by 6-methylhepta-3,5-dien-2-one in any of the strains, either in the absence or presence of S9. 
No precipitation was observed at any tested concentrations (Williams, 2009a). It is concluded that 
under the test conditions applied, 6-methylhepta-3,5-dien-2-one is not mutagenic in bacteria. 
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was evaluated in an in vitro micronucleus assay in 
human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in 
the presence and absence of rat S9 fraction as an in vitro metabolising system. The assay was 
performed in accordance with OECD 487 and in compliance with GLP. In a preliminary toxicity study 
a wide range of concentrations up to 2000 μg/ml of 6-methylhepta-3,5-dien-2-one was tested. The 
highest concentration used in the main test (450 μg/ml) was limited by toxicity observed in the 
preliminary study. Cells were stimulated for 48 hours with phytohaemaglutinin to produce 
exponentially growing cells, and then treated for 3 hours (followed by 21 hours recovery) with 0, 225, 
325 or 450 μg/ml of 6-methylhepta-3,5-dien-2-one in the absence of S9 and 0, 225, 300 and 350 μg/ml 
in the presence of S9, respectively. The levels of toxicity (reduction in replication index) at the top 
concentrations were 60 % and 51 % without and with S9, respectively. In a parallel assay, cells were 
treated for 24 hours with 0, 100, 120 or 150 μg/ml of 6-methylhepta-3,5-dien-2-one in the absence of 
S9 with no recovery period. The top concentration induced 56 % toxicity. There were 2 replicate 
cultures per treatment, and 1000 binucleate cells per replicate (i.e. 2000 cells per dose) were scored for 
                                                     
7 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
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micronuclei. No evidence of chromosomal damage or aneuploidy was observed by increased levels of 
micronucleated binucleate cells (MNBN) in the presence or absence of S9 metabolic activation 
(Whitwell, 2010a). Under the conditions of this study, 6-methylhepta-3,5-dien-2-one was not 
clastogenic and/aneugenic in cultured human lymphocytes. 
For a summary of in vitro genotoxicity data considered by EFSA see Table 2.4. 
Conclusion on Genotoxicity 
The Panel concluded that the in vitro genotoxicity data on 6-methylhepta-3,5-dien-2-one [FL-no: 
07.099] do not indicate genotoxic potential. 
3.4. EFSA Considerations 
The Panel concluded that the data available do not preclude evaluation of the 19 aliphatic secondary 
alcohols, ketones and related esters through the Procedure. 
4. Application of the Procedure 
4.1. Application of the Procedure to 19 Aliphatic Secondary Alcohols, Ketones and Related 
Esters by JECFA (JECFA, 2003a; JECFA, 2009c) 
According to the JECFA six of the substances belong to structural class I and 13 to structural class II 
using the decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
The JECFA concluded all 19 aliphatic secondary alcohols, ketones and related esters at step A3 in the 
JECFA Procedure – i.e. the substances are expected to be metabolised to innocuous products (step 2) 
and the intakes for all substances are below the thresholds for their structural classes I and II (step A3).  
In conclusion, the JECFA evaluated all 19 substances as to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the 19 aliphatic secondary alcohols, ketones and related esters are summarised in 
Table 3.1: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and Related 
Esters (JECFA, 2003a; JECFA, 2009c). 
4.2. Application of the Procedure to 49 Saturated and Unsaturated Aliphatic Secondary 
Alcohols, Ketones and Esters of Secondary Alcohols and Saturated Linear or 
Branched-chain Carboxylic Acids by EFSA, FGE.07Rev4 (EFSA, 2012d) 
Twenty-eight of the candidate substances [FL-no: 02.077, 02.124, 02.142, 02.148, 02.177, 02.182, 
02.183, 02.190, 02.255, 07.084, 07.178, 07.239, 09.304, 09.323, 09.325, 09.328, 09.332, 09.386, 
09.388, 09.391, 09.604, 09.605, 09.606, 09.608, 09.609, 09.676, 09.880 and 09.926] are classified in 
structural class I, according to the decision tree approach presented by Cramer et al. (Cramer et al., 
1978). The remaining 21 candidate substances [FL-no: 02.145, 02.194, 02.211, 07.072, 07.150, 
07.156, 07.157, 07.158, 07.160, 07.162, 07.181, 07.182, 07.185, 07.189, 07.198, 07.199, 07.201, 
07.204, 07.205, 07.236 and 07.262], which are unsaturated aliphatic secondary alcohols or acyclic 
aliphatic saturated or unsaturated ketones, are in structural class II. 
48 substances were concluded at step A3 using the EFSA Procedure – i.e. the substances are expected 
to be metabolised to innocuous products (step 2) and the estimated daily intakes for 48 substances are 
below the thresholds of concern for their structural classes (step A3). 
One candidate substance, 5-methylheptan-3-one [FL-no: 07.182], cannot be predicted to be 
metabolised to innocuous products and therefore, proceeds to step B3. The estimated daily intake of 
this substance of 0.32 microgram/capita/day does not exceed the threshold of concern for structural 
class II (540 microgram/person/day). Accordingly, the candidate substance proceeds to step B4 of the 
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Procedure. On the basis of a study on the neurotoxic effects of orally administered 5-methylheptan-3-
one [FL-no: 07.182] to male rats, a NOAEL of 82 mg/kg body weight (bw)/day was established (IBM 
Corp., 1989). This NOAEL provides a margin of safety of 1.5 x 107 based on the estimated intake of 
the candidate substance of 0.32 microgram/capita/day. Based on results of the safety evaluation 
sequence this candidate substance does not pose a safety concern when used as flavouring substance at 
the estimated level of intake, based on the MSDI approach. 
The stepwise evaluations of the 49 substances are summarised in Table 3.2: Summary of Safety 
Evaluation Applying the Procedure (EFSA, 2012d). 
4.3. EFSA Considerations 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 19 
substances in the group of aliphatic secondary alcohols, ketones and related esters. 
5. Conclusion 
In FGE.63 the EFSA evaluated 13 flavouring substances (EFSA, 2008ae) from a group of 39 
flavouring substances consisting of aliphatic secondary alcohols, ketones and related esters evaluated 
by the JECFA at its 59th meeting (JECFA, 2003a). At its 69th meeting the JECFA evaluated an 
additional 17 aliphatic secondary alcohols, ketones and related esters. The present revision of FGE.63, 
FGE.63Rev1, includes the consideration of six additional substances, 4,8-dimethyl-3,7-nonadien-2-ol, 
6-methylhepta-3,5-dien-2-one, octa-1,5-dien-3-one, (E,E)-3,5-octadien-2-one, (3Z)-4,8-dimethyl-3,7-
nonadiene-2-one and 4,8-dimethyl-3,7-nonadien-2-yl acetate [FL-no: 02.252, 07.099, 07.190, 07.247, 
07.256 and 09.936]. Three of these substances [FL-no: 07.099, 07.247 and 07.256] were evaluated by 
the JECFA at the 59th meeting (JECFA, 2003a) and three substances [FL-no: 02.252, 07.190 and 
09.936] were evaluated by the JECFA at its 69th meeting (JECFA, 2009c). These six substances are 
α,β-unsaturated ketones or may be metabolised to α,β-unsaturated ketones and were originally 
allocated to and evaluated in FGE.206 (EFSA, 2011c) in which they were considered not to be of 
concern with respect to genotoxicity. Therefore, the present revision of FGE.63, FGE.63Rev1 
considers 19 flavouring substances evaluated by the JECFA.  
The Panel concluded that the six additional substances fit well together with the 13 aliphatic secondary 
alcohols, ketones and related esters considered in the FGE.63. 
The Panel concluded that the 19 substances in the JECFA flavouring group of aliphatic secondary 
alcohols, ketones and related esters are structurally related to the group of 49 saturated and unsaturated 
aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated linear or 
branched-chain carboxylic acids evaluated in the Flavouring Group Evaluation 07, Revision 4 
(FGE.07Rev4). 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 19 
substances considered in this FGE.  
For all 19 substances the JECFA evaluation is based on MSDI values derived from production figures 
from the EU. 
For three candidate substances [FL-no: 02.252, 07.190 and 09.936], the Industry has submitted normal 
and maximum use levels. For [FL-no: 02.252 and 09.936], which are expected to be metabolised to 
innocuous products, the mTAMDI values are below their respective thresholds of concern for 
structural class I (1800 microgram/person/day) and class II (540 microgram/person/day). For 
substance [FL-no: 07.190] the mTAMDI value is above the threshold of concern for structural class II 
of 540 microgram/person/day to which it is allocated. Therefore, for this substance more reliable 
exposure data are required. On the basis of such additional data, the flavouring substance should be 
reconsidered along the steps of the Procedure. Following this procedure additional toxicological data 
might become necessary. For the remaining 16 substances evaluated through the Procedure use levels 
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are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more 
refined exposure assessment in order to finalise the evaluation 
In order to determine whether the conclusion for the 19 JECFA-evaluated substances can be applied to 
the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity are available for all 19 JECFA-evaluated 
substances.  
Thus, for all 19 JECFA evaluated aliphatic secondary alcohols, ketones and related esters [FL-no: 
02.252, 07.015, 07.069, 07.099, 07.100, 07.114, 07.123, 07.151, 07.190, 07.240, 07.247, 07.249, 
07.256, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] the Panel agrees with the JECFA 
conclusion “no safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY  
Table 1: Specification Summary of the Substances in the JECFA Flavouring Groups of Aliphatic Secondary Alcohols, Ketones and related Esters (JECFA, 2003a; 
JECFA, 2009c) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
02.252 
1841 
4,8-Dimethyl-3,7-nonadien-2-ol 
 
4102 
 
67845-50-5 
Liquid 
C11H20O 
168 
Insoluble 
Soluble 
70 (2.6 hPa) 
 
IR NMR 
95 % 
1.465-1.473 
0.860-0.870 
 
Racemate. Mixture of E/Z 
stereoisomers: 50-80 % (E) 
(EFFA, 2012c). 
07.015 
1120 
6-Methylhept-5-en-2-one 
 
2707 
149 
110-93-0 
Liquid 
C8H14O 
126.19 
Insoluble 
Miscible 
173.1 
 
NMR 
97 % 
1.435-1.445 
0.846-0.854 
 
 
07.069 
1121 
Tetrahydro-pseudo-ionone 
 
3059 
2053 
4433-36-7 
Liquid 
C13H24O 
196.33 
Insoluble 
Miscible 
234 
 
NMR 
95 % 
1.449-1.455 
0.865-0.875 
 
Racemate (EFFA, 2010a). 
07.099 
1134 
6-Methylhepta-3,5-dien-2-one 
 
3363 
11143 
1604-28-0 
Liquid 
C8H12O 
124.18 
Almost insoluble 
Miscible 
190 
 
NMR 
96 % 
1.528-1.537 
0.895-0.899 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012c). 
07.100 
1119 
5-Methylhex-5-en-2-one 
 
3365 
11150 
3240-09-3 
Liquid 
C7H12O 
112.17 
Insoluble 
Miscible 
148-149 
 
NMR 
97 % 
1.428-1.433 
0.862-0.868 
 
 
07.114 
1123 
6,10,14-Trimethylpentadeca-5,9,13-
trien-2-one 
 
3442 
11206 
762-29-8 
Liquid 
C18H30O 
262.44 
Soluble 
Miscible 
147-148 
 
NMR 
96 % 
1.478-1.483 
0.885-0.895 
 
Mixture of (5E,9E)-, 
(5Z,9Z)-, (5E,9Z)- and 
(5Z,9E)-isomers (EFFA, 
2010a).  
07.123 
1122 
Geranylacetone 
 
3542 
11088 
3796-70-1 
Liquid 
C13H22O 
194.32 
Slightly soluble 
Miscible 
247 
 
NMR 
95 % 
1.463-1.471 
0.861-0.867 
 
CASrn refers to (E)-isomer. 
Register name to be changed 
to (E)-Geranylacetone. 
07.151 
1118 
Decan-3-one 
 
3966 
11056 
928-80-3 
Liquid 
C10H20O 
156.27 
Insoluble 
Miscible 
204-205 
 
NMR 
97 % 
1.421-1.427 
0.820-0.830 
 
 
07.190 
1848 
Octa-1,5-dien-3-one 
 
4405 
 
65213-86-7 
Liquid 
C8H12O 
124.18 
Practically insoluble 
or insoluble 
Freely soluble 
169 
 
MS 
95 % 
1.438-1.444 
0.823-0.829 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012c). 
07.240 
1156 
2-Methylheptan-3-one 
 
4000 
 
13019-20-0 
Liquid 
C8H16O 
128.2 
Insoluble 
Miscible 
158-160 
 
NMR 
98 % 
1.408-1.413 
0.811-0.821 
 
 
OH
O
O
O
O
O
(5E), (9E)-isomer shown
O
O
O
O
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Table 1: Specification Summary of the Substances in the JECFA Flavouring Groups of Aliphatic Secondary Alcohols, Ketones and related Esters (JECFA, 2003a; 
JECFA, 2009c) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
EFSA comments 
07.247 
1139 
(E,E)-3,5-Octadien-2-one 
 
4008 
 
30086-02-3 
Liquid 
C8H12O 
124.2 
Insoluble 
Miscible 
220 
 
NMR 
95 % 
1.508-1.516 
0.880-0.890 
 
 
07.249 
1155 
Undecan-6-one 
 
4022 
 
927-49-1 
Liquid 
C11H22O 
170.3 
Insoluble 
Miscible 
228 
 
NMR 
97 % 
1.424-1.430 
0.826-0.836 
 
 
07.256 
1137 
(3Z)-4,8-Dimethyl-3,7-nonadiene-2-
one 
 
3969 
 
817-88-9 
Liquid 
C11H18O 
166.26 
Insoluble 
Freely soluble 
200-201 
n.a. 
IR NMR 
94 % 
1.473-1.477 
0.869-0.875 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012c). Register 
name to be changed to 4,8-
Dimethyl-3,7-nonadiene-2-
one.  
09.657 
1146 
1-Methylbutyl acetate 
 
4012 
10761 
626-38-0 
Liquid 
C7H14O2 
130.2 
Insoluble 
Partially Soluble 
135 
 
NMR 
98 % 
1.369-1.400 
0.862-0.866 
 
Racemate (EFFA, 2010a).  
09.658 
1142 
1-Methylbutyl butyrate 
 
3893 
10763 
60415-61-4 
Liquid 
C9H18O2 
158.24 
Insoluble 
50% Soluble 
185-186 
 
IR NMR MS 
99 % 
1.409-1.415 
0.862-0.868 
 
Racemate (EFFA, 2010a). 
09.923 
1144 
Hept-2-yl butyrate 3981 
 
39026-94-3 
Liquid 
C11H22O2 
186.3 
Insoluble 
Miscible 
210 
 
NMR 
98 % 
1.413-1.417 
0.855-0.860 
 
Racemate (EFFA, 2010a).  
09.924 
1143 
(+/-)-3-Heptyl acetate 3980 
 
5921-83-5 
Liquid 
C9H18O2 
158.2 
Insoluble 
Miscible 
185 
 
NMR 
98 % 
1.406-1.414 
0.858-0.867 
 
Racemate. 
Register name to be changed 
to 3-Heptyl acetate. 
09.925 
1145 
Nonan-3-yl acetate 4007 
 
60826-15-5 
Liquid 
C11H22O2 
186.3 
Insoluble 
Miscible 
225 
 
NMR 
98 % 
1.416-1.423 
0.854-0.864 
 
Racemate (EFFA, 2010a).  
09.936 
1847 
4,8-Dimethyl-3,7-nonadien-2-yl 
acetate 
4103 
 
91418-25-6 
Liquid 
C13H22O2 
210 
Insoluble 
Soluble 
75-83 (3 hPa) 
 
IR NMR 
95 % 
1.451-1.459 
0.890-0.900 
 
Racemate. Mixture of E/Z 
stereoisomers: 50-80 % (E) 
(EFFA, 2012c). 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 % ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
O
O
O
O
O
O
O
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O
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TABLE 2: GENOTOXICITY DATA  
Table 2.1: Summary of Genotoxicity Data of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003a) 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural formula End-point Test system Concentration Results Reference 
In vitro 
07.015 
1120 
6-Methylhept-5-en-2-one Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
380 µg/plate Negative1 (Florin et al., 1980) 
07.099 
1134 
6-Methyl-3,5-heptadien-2-
one 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
370 µg/plate Negative1 (Florin et al., 1980) 
1  With and without metabolic activation. 
 
  
O
O
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Table 2.2: Summary of Genotoxicity Data (in vitro) EFSA / FGE.07 (EFSA, 2012d) (substances in brackets are JECFA-evaluated substances) 
Chemical Name [Fl.No.] Test system Test Object Concentration Result Reference Comments 
(Acetone [07.050]) Rec assay B. subtilis NR Negative 1 (Kawachi et al., 1980a) 8 
Rec assay B. subtilis NR Negative (Ishizaki et al., 1979) 8 
Ames test S. typhimurium TA100 0.1 to 1000 µg/plate Negative (Rapson et al., 1980) 8 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537 
174 µg/plate Negative 1 (Florin et al., 1980) 8 
Ames test S. typhimurium TA98, TA100 NR Negative 1 (Kawachi et al., 1980a) 8 
Ames test 2 S. typhimurium TA98, TA100 30 µl/plate Negative 4 (Yamaguchi, 1985) 8 
Ames test S. typhimurium TA97, TA98, 
TA100, TA1535, TA1537 
Up to 10000 µg/plate Negative 1 (McCann et al., 1975) 8 
Ames test 2 S. typhimurium TA97, TA98, 
TA100, TA1535, TA1537 
Up to 10000 µg/plate Negative 1 (Zeiger et al., 1992) 8 
Ames test S. typhimurium TA100 500 µg/plate Negative 1 (Yamaguchi, 1982) 8 
Ames test S. typhimurium TA97, TA98, 
TA100 
20 to 40 µg Negative 1 (Azizan and Blevins, 1995) 8 
Sister chromatid 
exchange 
Human embryo fibroblasts NR Negative 4 (Kawachi et al., 1980a) 8 
Sister chromatid 
exchange 
Hamster lung fibroblasts NR Negative 4 (Kawachi et al., 1980a) 8 
Sister chromatid 
exchange 
Chinese hamster ovary cells Up to 10 µg/ml Negative (Sasaki et al., 1980) 8 
Sister chromatid 
exchange 
Chinese hamster ovary cells Up to 5020 µg/ml Negative 1 (Loveday et al., 1990) 8 
Sister chromatid 
exchange 
Diploid human fibroblasts 5 µg/ml Negative (Sasaki et al., 1980) 8 
Sister chromatid 
exchange 
Human lymphocytes 395 µg/ml Negative (Norppa et al., 1983) 8 
Sister chromatid 
exchange 
Human lymphocytes 0.1 to 1 mM Negative (Zarani et al., 1999) 8 
Chromosomal aberrations Chinese hamster ovary cells Up to 5020 µg/ml Negative 1 (Loveday et al., 1990) 8 
Chromosomal aberrations Hamster lung fibroblasts NR Positive 4 (Kawachi et al., 1980a) 8 
Aneuploidy induction S. cerevisiae 6.98-7.83 % Positive 4 (Zimmermann et al., 1985a) 10 
(Isopropyl alcohol [02.079]) Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537 
174 µg/plate Negative 1 (Florin et al., 1980) 8 
Ames test 2 S. typhimurium TA98, TA100, 
TA1535, TA1537, E. coli WP2uvrA 
5 to 5000 µg/plate Negative 1 (Shimizu et al., 1985) 8 
Ames test 2 S. typhimurium TA97, TA98, 
TA100, TA102, TA104, TA1535, 
TA1537 
Up to 10 mg/plate 5 Negative 1 (Zeiger et al., 1992) 8 
Forward mutation Chinese hamster ovary cells 6 0.5 to 5.0 mg/ml Negative 1 (CMA, 1990) 8 
Forward mutation Chinese hamster ovary cells 6 0.5 to 5.0 mg/ml Negative 1 (Kapp et al., 1993a) 8 
(2-Butanone [07.053]) Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
10000 µg/plate Negative 1 (Douglas et al., 1980) 8 
Ames test S. typhimurium TA102, TA104 1 mg/plate Negative (Marnett et al., 1985a) 8 
 Ames test 2 S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
5 to 5000 µg/plate Negative 1 (Shimizu et al., 1985) 8 
Ames test S. typhimurium TA98, TA100, 0.04 to 26 µg/plate Negative 1 (O’Donoghue et al., 1988) 8 
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TA1535, TA1537, TA1538 
Ames test 2 S. typhimurium TA97, TA98, 
TA100, TA104, TA1535, TA1537 
Up to 10000 µg/plate Negative 1 (Zeiger et al., 1992) 8 
Ames test S. typhimurium TA102 5000 µg/plate Negative 4 (Müller et al., 1993) 8 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538,  
E. coli WP2uvrA 
4000 µg/plate Negative (Brooks et al., 1988) 8 
Gene conversion S. cerevisiae 5 mg/ml Negative 1 (Brooks et al., 1988) 8 
Forward Mutation L5178Y/TL+/- mouse lymphoma 
cells 
0.67 to 12 µg/ml Negative 1 (O’Donoghue et al., 1988) 8 
Unscheduled DNA 
synthesis 
Human lymphocytes 0.72 mg/ml Negative 1 (Perocco et al., 1983) 8 
Unscheduled DNA 
synthesis 
Rat hepatocytes 7.2 to 360 mg/ml Negative (O’Donoghue et al., 1988) 8 
Chromosomal aberrations Rat hepatocytes 1000 µg/ml Negative (Brooks et al., 1988) 8 
Chromosomal aberrations Chinese hamster ovary cells 1000 µg/ml Negative 1 (Brooks et al., 1988) 8 
Cell transformation assay1 BALB/3T3 cells (clone A31-1) 6-18 µl/ml Negative (O’Donoghue et al., 1988)  
Aneuploidy induction S. cerevisiae 3.38 % Positive 4 (Zimmermann et al., 1985a) 11 
Pentan-3-one [07.084] Aneuploidy induction S. cerevisiae 1.48 % Positive 4 (Zimmermann et al., 1985a) 11 
Pentan-3-ol [02.077] Chromosomal aberrations Chinese hamster ovary cells 0.5 to 10 % Negative 1 (Abbondandolo et al., 1980)  
Forward mutation S. pombe 0.5 to 10 % Negative 1 (Abbondandolo et al., 1980)  
(2-Heptanone [07.002]) Unscheduled DNA 
synthesis 
Rat hepatocytes 1000 ppm Negative (Barber et al., 1999)  
Methyl-3-butan-2-one 
[07.178] 
Aneuploidy induction S. cerevisiae 1.23 to 1.36 % Negative 4 (Zimmermann et al., 1985a) 11 
Aneuploidy induction S. cerevisiae 0.84 to 1.23 % Negative 4 (Zimmermann et al., 1985a) 11 
(4-Methyl-2-pentanone 
[07.017]) 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
0.03 to 3 mg/plate Negative 1 (O’Donoghue et al., 1988) 8 
Ames test 2 S. typhimurium TA97, TA98, 
TA100, TA1535 
Up to 6667 µg/plate Negative 1 (Zeiger et al., 1992) 8 
Ames test E. coli WP2uvrA 8000 µg/plate Negative 4 (Brooks et al., 1988) 8 
Gene conversion S. cerevisiae 5 mg/ml Negative 1 (Brooks et al., 1988) 8 
Forward mutation L5178Y/TL+/- mouse lymphoma 
cells 
0.26 to 3.7 µg/ml Negative 1 (O’Donoghue et al., 1988) 8 
Unscheduled DNA 
synthesis 
Rat hepatocytes 8 to 80 µg/ml Negative (O’Donoghue et al., 1988)  8 
Chromosomal aberrations Rat hepatocytes 1000 µg/ml Negative (Brooks et al., 1988) 8 
Cell transformation assay1 BALB/3T3 cells (clone A31-1) 1-7µl/ml Negative (O’Donoghue et al., 1988)  
Chromosomal aberrations Chinese hamster ovary cells 1000 µg/ml Negative 1 (Brooks et al., 1988) 8 
Methyl-4-pentan-2-ol 
[02.183] 
Ames test 2 S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538, E. coli 
WP2uvrA 
5000 µg Negative 1 (Shimizu et al., 1985)  
Methyl-6-heptan-2-one 
[07.181] 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537 
5000 µg/plate Negative 1 (BASF, 1989a)  
(2,6-Dimethyl-4-heptanone 
[07.122]) 
Ames test 2 S. typhimurium TA98, TA100, 
TA1535, TA1537 
1 to 333 µg/plate Negative 1 (Mortelmans et al., 1986) 8 
Trimethyl-6,10,14-
pentadecan-2-one [07.205] 
Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537 
5000 µg/plate Negative 1 (BASF, 1989b)  
(6-Methyl-5-hepten-2-one 
[07.015]) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
380 µg/plate Negative 1 (Florin et al., 1980) 9 
(Isopropyl acetate [09.003]) Ames test 2 S. typhimurium TA97, TA98, 
TA100, TA1537, TA1538 
Up to 10 mg/plate Negative 1 (Zeiger et al., 1992) 8 
(Isopropyl myristate 
[09.105]) 
Ames test 7 S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
50 µg/plate Negative 1 (Blevins and Taylor, 1982) 8 
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Isopropyl hexadecanoate 
[09.606] 
Ames test 7 S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
50 µg/plate Negative 1 (Blevins and Taylor, 1982)  
9-Decen-2-one [07.262] Ames test10 S. typhimurium TA98, TA100, 
TA1535, TA1537 
Up to 5 µL/plate Negative1 (Flavour Industry, 
2009m) 
 Ames test10 E. coli WP2 (pKM 101) Up to 5 µL/plate Negative1 (Flavour Industry, 
2009m) 
(6-Methylhepta-3,5-dien-2-
one [07.099]) 
Reverse mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 
370 µg/plate Negative1 (Florin et al., 1980)              9 
 Reverse Mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 and TA102 
1.6, 8, 40, 200, 1000 
and 5000 μg/plate   
Negative1 (Williams, 2009a) Toxicity observed in all strains at 2000 μg/plate or greater in 
 the absence of S9 and at 800 μg/plate in the presence of S9. 
Study design complied with current recommendations.  
Acceptable top concentration was achieved. 
 Micronucleus induction Human peripheral blood 
lymphocytes 
225, 325 and 450 μg/ml 
13 225, 300 and 350 
μg/ml 14 
Negative (Whitwell, 2010a) Complies with draft OECD Guideline 487. Acceptable levels 
 of cytotoxicity achieved at the top concentrations used in all 
 parts of the study. 
Pseudo-ionone [07.198] Ames test S. typhimurium TA98, TA100, 
TA1535, TA1537 
0.03 to 30 µmol/plate Negative (Florin et al., 1980) 
 Reverse Mutation S. typhimurium TA98, TA100, 
TA1535, TA1537 and TA102 
0.128, 0.64, 3.2, 16, 80, 
400 and 2000 μg/plate  
Negative1 (Beevers, 2009a) Toxicity was observed in all strains at 400 μg/plate and 
greater in the presence and absence of S9 in this experiment. 
   0.12.5, 25, 50, 100, 200 
and 400 μg/plate 12 
Negative1  Precipitation was observed in the 400 μg/plate concentration 
in the presence and absence of S9 in this experiment. Study 
design complies with current recommendations. Acceptable 
top concentrations were achieved. 
 Micronucleus induction Human peripheral blood 
lymphocytes 
30, 50 and 60 μg/ml13 
100, 110 and 120 
μg/ml14 
Negative (Lloyd, 2010a) Complies with draft OECD guideline 487. Acceptable levels 
of cytotoxicity achieved at the top concentrations used in all 
parts of the study. 
 Micronucleus induction Human peripheral blood 
lymphocytes 
10, 15 and 20 μg/ml15 Negative (Lloyd, 2010a) Complies with draft OECD guideline 487. Acceptable levels 
of cytotoxicity achieved at the top concentrations used in all 
parts of the study. 
1. Assay performed with and without metabolic activation. 
2. Modified Ames (Pre-incubation) protocol. 
3. Assay performed with S9 metabolic activation. 
4. Assay performed without S9 metabolic activation. 
5. Maximum non-toxic dose. 
6. HGPRT locus. 
7. Spot test. 
8. Summarised by JECFA, 51st meeting (JECFA, 1999a). 
9. Summarised by JECFA 59th meeting (JECFA, 2003a). 
10. Direct incorporation method. 
11. Unusual experimental protocol for detection of aneuploidy, which can be considered a threshold effect not mediated by a direct interaction with DNA. Positive results were obtained at concentrations approaching cytotoxic levels and are very 
likely due to the presence of technical artefacts (low temperature treatment inducing tubulin dissociation). Indeed, absence of effect was recorded when the ice treatment was skipped. – The limited relevance of fungal systems together with the 
uncertain quality of these results make questionable their extrapolation to the in vivo situation in humans. 
12. Assay modified with pre-incubation in the presence of S9. 
13. Without metabolic activation, 3 hours treatment + 21 hours recovery. 
14. With metabolic activation, 3 hours treatment + 21 hours recovery. 
15. Without metabolic activation, 24 hours + 0 hours recovery. 
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Table 2.3: Summary of Genotoxicity Data (in vivo) EFSA / FGE.07Rev4 (EFSA, 2012d) (substances in brackets are JECFA-evaluated substances) 
Chemical Name Test system Test Object Route Dose Result Reference Comments 
(Isopropyl alcohol [02.079]) Micronucleus test  ICR Mouse (15M & 15F)  i.p. injection in 0.9% NaCl 350 - 2500 mg/kg Negative (Kapp et al., 1993a) 1 
(Acetone [07.050]) Micronucleus test Chinese hamster (5M & 5F) i.p. injection in corn oil 865 mg/kg Negative (Basler, 1986) 1 
(2-Butanone [07.053]) Micronucleus test CD-1 mice (5M & 5F) i.p. injection in corn oil LD20 (1.96 ml/kg) Negative (O’Donoghue et al., 1988) 1 
Micronucleus test Chinese hamster (5M & 5F) i.p. injection in corn oil 411mg/kg Negative (Basler, 1986) 1 
(4-Methyl-2-pentanone 
[07.017]) 
Micronucleus test CD-1 mice (5M & 5F) i.p. injection in corn oil LD20 (0.73 ml/kg) Negative (Basler, 1986) 1 
1. Summarised by JECFA, 51st meeting (JECFA, 1999a). 
 
Table 2.4: GENOTOXICITY (in vitro) Summary of Additionally submitted genotoxicity data on the representative substance of subgroup 1.2.3 
FL-no Chemical Name Test System in vitro  Test Object  Concentrations of Substance 
and Test Conditions  
Result  Reference  Comments  
[07.099] 6-Methylhepta-3,5-dien-
2-one  
Reverse Mutation S. typhimurium TA98, 
TA100, TA1535, 
TA1537 and TA 102 
1.6, 8, 40, 200, 1000 and 5000 
μg/plate [1]  
Negative (Williams, 
2009a) 
Toxicity observed in all strains at 2000 μg/plate 
or greater in the absence of S9 and at 800 
μg/plate in the presence of S9. Study design 
complied with current recommendations. 
Acceptable top concentration was achieved. 
20.48, 51.2, 128, 320, 800, 
2000 and 5000 μg/plate [1,2] 
Negative 
Micronucleus induction Human peripheral blood 
lymphocytes 
225, 325 and 450 μg/ml [3] 
225, 300 and 350 μg/ml [4] 
Negative (Whitwell, 
2010a) 
Complies with draft OECD guideline 487. 
Acceptable levels of cytotoxicity achieved at 
the top concentrations used in all parts of the 
study. 100, 120 or 150 μg/ml [5] Negative 
[1] With and without metabolic activation. 
[2] Assay modified with pre-incubation in the presence of S9. 
[3] Without metabolic activation, 3 hours treatment + 21 hours recovery. 
[4] With metabolic activation, 3 hours treatment + 21 hours recovery. 
[5] Without metabolic activation, 24 hours + 0 hours recovery. 
Flavouring Group Evaluation 63, Revision 1
 
EFSA Journal 2012;10(10):2900  24
TABLE 3: SUMMARY OF SAFETY EVALUATIONS 
Table 3.1: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003a; JECFA, 2009c) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on 
the material of 
commerce 
02.252 
1841 
4,8-Dimethyl-3,7-nonadien-2-ol 
 
3.0 
 
Class I 
A3: Intake below threshold 
4) Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at estimated levels 
of intake based on the 
MSDI approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
09.657 
1146 
1-Methylbutyl acetate 
 
2.9 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at 
estimated levels of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
09.658 
1142 
1-Methylbutyl butyrate 
 
0.47 
1 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
09.923 
1144 
Hept-2-yl butyrate 3.0 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
09.924 
1143 
(+/-)-3-Heptyl acetate 
 
3.0 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
 No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
EU Register name to 
be changed to 3-
Heptyl acetate. 
09.925 
1145 
Nonan-3-yl acetate 3.0 
3 
Class I 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.015 
1120 
6-Methylhept-5-en-2-one 
 
100 
44 
Class II 
A3: Intake below threshold 
4) No safety concern at 
estimated levels of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.069 
1121 
Tetrahydro-pseudo-ionone 
 
0.012 
0.01 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.099 
1134 
6-Methylhepta-3,5-dien-2-one 
 
13 
5 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at estimated levels 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
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Table 3.1: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003a; JECFA, 2009c) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on 
the material of 
commerce 
of intake based on the 
MSDI approach. 
07.100 
1119 
5-Methylhex-5-en-2-one 
 
0.24 
0.3 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.114 
1123 
6,10,14-Trimethylpentadeca-5,9,13-
trien-2-one 
 
0.085 
 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.123 
1122 
Geranylacetone 
 
41 
2 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
Register name to be 
changed to (E)-
Geranylacetone. 
07.151 
1118 
Decan-3-one 
 
3.0 
3 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.190 
1848 
Octa-1,5-dien-3-one 
 
0.061 
 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at estimated levels 
of intake based on the 
MSDI approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.240 
1156 
2-Methylheptan-3-one 
 
3.0 
3 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.247 
1139 
(E,E)-3,5-Octadien-2-one 
 
3.0 
4 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at estimated levels 
of intake based on the 
MSDI approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.249 
1155 
Undecan-6-one 
 
3.0 
3 
Class II 
A3: Intake below threshold 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.256 
1137 
(3Z)-4,8-Dimethyl-3,7-nonadiene-
2-one 
6.1 
6.6 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at estimated levels 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
O
O
(5E), (9E)-isomer shown
O
O
O
O
O
O
O
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Table 3.1: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003a; JECFA, 2009c) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on 
the material of 
commerce 
of intake based on the 
MSDI approach. 
Register name to be 
changed to 4,8-
Dimethyl-3,7-
nonadiene-2-one. 
09.936 
1847 
4,8-Dimethyl-3,7-nonadien-2-yl 
acetate 
 
3.0 
 
Class II 
A3: Intake below threshold 
4) Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at estimated levels 
of intake based on the 
MSDI approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
 
ND: not determined 
  
O
O
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
02.077 
 
Pentan-3-ol 0.19 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.124 
 
6-Methylhept-5-en-2-ol 0.0061 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.142 
 
3,3-Dimethylbutan-2-ol 
 
0.24 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.148 
 
Dodecan-2-ol 0.35 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.177 
 
2-Methylhexan-3-ol 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.182 
 
3-Methylpentan-2-ol 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.183 
 
4-Methylpentan-2-ol 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.190 
 
Nonan-3-ol 0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.255 
 
(Z)-4-Hepten-2-ol 0.03 
 
Class I 
A3: Intake below threshold 
4) 6)  
07.084 
 
Pentan-3-one 0.24 
 
Class I 
A3: Intake below threshold 
4) 6)  
07.178 
 
3-Methylbutan-2-one 
 
0.073 
 
Class I 
A3: Intake below threshold 
4) 6)  
07.239 
1840 
[R-(E)]-5-Isopropyl-8-
methylnona-6,8-dien-2-one 
0.24 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.304 
 
sec-Heptyl isovalerate 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.323 
 
sec-Butyl acetate 0.0012 
 
Class I 
A3: Intake below threshold 
4) 6)  
OH
OH
OH
OH
OH
OH
OH
OH
OH
O
O
O
O
O
O
O
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
09.325 
 
sec-Butyl butyrate 1.3 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.328 
 
sec-Butyl formate 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.332 
 
sec-Butyl hexanoate 0.024 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.386 
 
sec-Hept-4(cis)-enyl acetate 0.024 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.388 
 
sec-Heptyl acetate 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.391 
 
sec-Heptyl hexanoate 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.604 
 
Isopropyl decanoate 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.605 
 
Isopropyl dodecanoate 0.12 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.606 
 
Isopropyl hexadecanoate 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.608 
 
Isopropyl octanoate 1.3 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.609 
 
Isopropyl valerate 0.012 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.676 
 
sec-Octyl acetate 0.011 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.880 
 
Hept-4-enyl-2 butyrate 0.79 
 
Class I 
A3: Intake below threshold 
4) 6)  
09.926 
 
Octan-3-yl formate 0.24 
 
Class I 
A3: Intake below threshold 
4) 6)  
02.145 
 
2,6-Dimethylocta-1,5,7-trien-3-ol 0.0085 
 
Class II 
A3: Intake below threshold 
4) 6) a) 
02.194 
 
Octa-1,5-dien-3-ol 0.061 
 
Class II 
A3: Intake below threshold 
4) 6) a) 
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
O
(E)- isomer shown
O
O
OH
OH
Flavouring Group Evaluation 63, Revision 1
 
EFSA Journal 2012;10(10):2900  29
Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
02.211 
 
Undeca-1,5-dien-3-ol 0.061 
 
Class II 
A3: Intake below threshold 
4) 6) a) 
07.072 
 
6-Methylheptan-3-one 0.19 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.150 
 
Decan-2-one 0.52 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.156 
 
2,6-Dimethyloct-6-en-3-one 0.0012 
 
Class II 
A3: Intake below threshold 
4) 7)  
07.157 
 
6,10-Dimethylundecan-2-one 0.085 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.158 
 
Dodecan-2-one 0.73 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.160 
 
Heptadecan-2-one 0.12 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.162 
 
Hex-5-en-2-one 0.049 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.181 
 
6-Methylheptan-2-one 0.0012 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.185 
 
3-Methylpentan-2-one 1.2 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.189 
 
Nonan-4-one 0.52 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.198 
 
Pseudo-ionone 0.12 
 
Class II 
A3: Intake below threshold 
4) 6) a) 
07.199 
 
Tetradecan-2-one 0.073 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.201 
 
Tridec-12-en-2-one 0.024 
 
Class II 
A3: Intake below threshold 
4) 6)  
OH
O
O
O
(E)- isomer shown
O
O
O
O
O
O
O
O
O
O
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Table 3.2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
07.204 
 
3,3,6-Trimethylhepta-1,5-dien-4-
one 
0.012 
 
Class II 
A3: Intake below threshold 
4) 6) a) 
07.205 
 
6,10,14-Trimethylpentadecan-2-
one 
0.0073 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.236 
 
5-Octen-2-one 0.0097 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.262 
 
9-Decen-2-one 73 
 
Class II 
A3: Intake below threshold 
4) 6)  
07.182 
 
5-Methylheptan-3-one 
 
0.32 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6) b) 
 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
a) Evaluated in FGE.206, genotoxicity concern could be ruled out. 
b) NOAEL for neurotoxicity: 82 mg/kg bw/day; Adequate Margin of Safety. 
 
 
O
O
O
(Z)-isomer shown
O
O
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ABBREVIATIONS 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good laboratory practise 
ID  Identity 
Ip  Intraperitoneal 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic erythrocyte 
No  Number 
NOAEL No observed adverse effect level 
NTP  National Toxicology Program 
PCE  Polychromatic erythrocyte 
SCE  Sister chromatic exchange 
SCF  Scientific Committee on Food 
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WHO  World Health Organisation 
 
